Adherence to Infective Endocarditis Prevention Guidelines by Israeli Dentists Who Treat Children
Publication date: October 2018Source: Canadian Journal of Cardiology, Volume 34, Issue 10, Supplement 1Author(s): B. Macknak, B. Leis, C. Guenther, S. Peermohamed, E. PausJenssen, J. Kosar, A. Zhai
ConclusionsInitial results with the CardioCel patch in mitral valve repair operations were satisfactory. The resistance to infection and late degeneration will need to be assessed in the future.
Publication date: Available online 18 September 2018Source: The Egyptian Heart JournalAuthor(s): Meriem Drissa, Farah Amani, Habiba Drissa
Daptomycin, is a cyclic lipopeptide antibiotic with potent bactericidal activity against most Gram-positive organisms including vancomycin resistant enterococci, methicillin-resistant staphylococci, and “heterodrug-resistant” glycopeptide-resistant Staphylococcus aureus . Daptomycin is indicated for the treatment of complicated skin and soft tissue infections (cSSTIs) caused by susceptible strains of Gram-positive microorganisms and is approved for the treatment of Staphylococcus aureus blo odstream infections and right-sided infective endocarditis (IE).
Staphylococcus aureus remains one of the dominant pathogens in infective endocarditis (IE) causing 25% to 30% of all cases [1,2] including healthcare-associated IE which comprises about 30% of IE . Most IE involve the aortic or mitral valves, with tricuspid valve involvement accounting for fewer than 10% of cases, often in association with injection drug use [1,4,5]. Prosthetic valve IE (PVE) and IE related to cardiovascular implantable electronic devices accounts for approximately one-third of all cases and is most commonly caused by coagulase-negative staphylococci [1,5].
Publication date: Available online 15 September 2018Source: Revista Española de Cardiología (English Edition)Author(s): Iria Silva Conde, Francisco Torres-Saura, Alberto Alperi García, Jesús María de la Hera Galarza
Conclusions: This algorithm will enable researchers to examine epidemiological trends in PWID-associated infective endocarditis.
Aerococcus species were first described in 1953. They have been previously described as the causative agent of urinary tract infections in the elderly but rarely the causative agent for severe infections. However, there are very few cases reported in the pediatric population. To our knowledge, we report the first case of an adolescent with infective endocarditis caused by Aerococcus urinae.
PMID: 30211946 [PubMed - in process]
The study analyzed microbiological and antimicrobial susceptibility profile of organisms isolated from patients with infective endocarditis (2015 –17) and compared disease outcomes in cohorts of endocarditis pa...